Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
The Moloney leukemia virus 10 (Mov10) protein is a newly discovered factor with broad-spectrum antiretroviral potential. The Mov10 protein belongs to the RNA helicase superfamily-1 (SF-1) and is a component of the RNA-induced silencing complex (RISC). In recent years, Mov10 related research has focused on its function in RNA interference (RNAi) and its inhibition of retrovirus replication such as HIV-1 and its mechanism. In addition, MOV10 can reduce the infectivity of other retroviruses such as sputum immunodeficiency virus, murine leukemia virus, equine infectious anemia virus.
Studies have shown that in the non-stress state, the cell Mov10 protein is expressed in the cytoplasmic p-bodies, and in the stress cells it is distributed in the cytoplasmic stress granules. Other studies have found that Mov10 protein is mainly expressed in the nucleus and is associated with staining. Studies have also shown that Mov10 protein can also be present in neuronal synapses. Mov10 protein is expressed in different degrees in different cell types, including embryonic stem cells. Mov10 can be highly expressed in different stages of organ development in testis and thymus. Moreover, Mov10 mRNA is highly expressed in human testis and ovary, and has a certain degree of expression in placenta and liver tissues. Studies have shown that Mov10 protein may be involved in ontogenesis and cell proliferation.
Figure 1. FMRP modulates an agonistic or antagonistic miRNA function through its interaction with MOV10. (Phillip, K., 2016)
Mov10 Antiretroviral Activity
Studies have shown that overexpression of Mov10 protein inhibits Gag protein stability by blocking Gag protein hydrolysis and inhibiting HIV-1 production during multiple viral replication processes. Studies have found that overexpression of Mov10 protein inhibits replication of HIV-1 virus before or during the transcriptional initiation. Other researchers believe that Mov10 protein does not block the entry of virus into cells, nor does it affect the expression of viral RNA in infected cells, but it can effectively inhibit the reverse transcription process of the virus. Studies have confirmed that overexpression of Mov10 protein has no significant inhibitory effect on the early reverse transcription of HIV-1 virus, and it is confirmed that Mov10 protein does not affect HIV-1 DNA integration and virus mutation rate.
Overexpression of Mov10 protein also reduces HIV-1 viral infectivity. The Mov10 protein interacts with the Gag nucleocapsid protein region in an RNA-dependent manner, enters the HIV-1 virion, and directly or indirectly blocks viral reverse transcription in the target cell, resulting in a 20- to 100-fold reduction in viral infectivity. Overexpression of the Mov10 protein results in a decrease in Gag protein during cell quiescence and a decrease in virus production. In addition, Mov10 protein can cause a decrease in viral minus-strand DNA synthesis in target cells, and may also reduce viral infectivity to some extent.
Other Biological Functions of Mov10
Mov10 is a telomerase-related protein, and the expression level of Mov10 mRNA and protein in cancer cells is 2 to 3 times higher than that in normal cells. The study speculated that the Mov10 protein binds to the telomere-rich-GDNA sequence, and its N-terminus forms a complex with hTERT, which is involved in telomerase-catalyzed telomere elongation. In addition, studies have indicated that the expression levels of Mov10 in different tissues and organs are highly consistent with telomerase activity. Mov10 has also been studied in association with melanoma. Experiments have shown that inhibition of Mov10 expression increases the expression levels of fatty acid synthase (FASN) and stearoyl-CoA dehydrogenase (SCD) and promotes lipid modification and secretion of Wnt5a Therefore, it can be inferred that Mov10 affects the secretion of Wnt5a by regulating lipid synthesis, which in turn affects the metastasis of melanoma cells.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.